metabolic · Mechanism Report
Does inflammation lower circulating zinc?
Inflammation can rapidly lower circulating zinc through hepatic redistribution rather than a true loss of total-body zinc.
This is what AI claimed
Inflammation lowers circulating zinc by increasing hepatic zinc sequestration through cytokine-driven metallothionein expression.
Executive summary
The claim says inflammatory cytokines can drive zinc into the liver, where metallothionein binding helps retain it and reduce the amount left in circulation. The mechanism framing supports an acute-phase redistribution response, with moderate confidence from experimental and clinical observations. This means a low serum zinc level during inflammation may reflect sequestration as well as nutritional status.
Verified conclusion
Inflammation can produce a rapid fall in circulating zinc through an acute-phase redistribution response rather than necessarily reflecting reduced total-body zinc stores. The proposed liver-centered pathway is supported with moderate confidence, particularly by experimental data.
Clinical and translational evidence
- Human experimental endotoxemia shows that serum zinc declines rapidly after rises in TNF-α and IL-6, consistent with cytokine-driven zinc redistribution during acute inflammation.
- In acutely ill older hospital populations, serum zinc was inversely associated with C-reactive protein in two groups (r = −0.33 and −0.29; both P < 0.001). Aged-care residents similarly had lower zinc concentrations alongside inflammatory markers.
- These associations vary across older populations, with some cohorts showing no zinc–CRP correlation and reports of sex-specific patterns. For a 71-year-old man, a low serum zinc result during illness or elevated CRP therefore warrants interpretation in its inflammatory context rather than being treated automatically as evidence of nutritional zinc deficiency.
Mechanistic evidence
- IL-6 promotes hepatocyte zinc uptake through induction of ZIP14, a zinc-importing transporter. In mice lacking IL-6, inflammation did not induce hepatic ZIP14 or the characteristic inflammatory hypozincemia.
- In rat hepatocytes, IL-6 increased metallothionein expression and intracellular zinc. Inflammatory animal models likewise show increased hepatic metallothionein and liver zinc.
- Metallothionein can bind intracellular zinc, providing a coherent mechanism by which cytokine-stimulated hepatic uptake retains zinc in the liver and lowers the circulating concentration.
Bottom line
- The claim is scientifically supported: inflammation-associated cytokines, particularly IL-6, can increase hepatic zinc uptake and metallothionein-mediated intracellular binding, contributing to lower circulating zinc. In clinical practice, serum zinc during active inflammation is best viewed as a marker influenced by redistribution as well as nutritional status.
References
- Interleukin 6 regulates metallothionein gene expression ... — pmc.ncbi.nlm.nih.gov
- Lack of a Role for Induced Zinc Deficiency or Metallothionein ... — academic.oup.com
- Acute phase reaction and acute phase proteins - PMC - NIH — pmc.ncbi.nlm.nih.gov
- Interleukin-6 regulates the zinc transporter Zip14 in liver and contributes to the hypozincemia of the acute-phase response | PNAS — pnas.org
- Interleukin-6 regulates the zinc transporter Zip14 in liver and contributes to the hypozincemia of the acute-phase response — pnas.org
- Zinc and Regulation of Inflammatory Cytokines - PMC - NIH — pmc.ncbi.nlm.nih.gov
- An inverse relationship between serum zinc and C-reactive protein levels in acutely ill elderly hospital patients — academic.oup.com
See a full patient report verified like this
Book a walkthrough